Addex Therapeutics (ADXN)
(Delayed Data from NSDQ)
$10.86 USD
+0.63 (6.16%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $10.86 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ADXN 10.86 +0.63(6.16%)
Will ADXN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ADXN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ADXN
Addex Stock Soars on Crucial Update From Indivior Research Deal
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?
ADXN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Alcon (ALC) Outperforming Other Medical Stocks This Year?
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates
Other News for ADXN
Clinical Collaboration Ignites Addex Therapeutics (ADXN) Stock Rally
Analysts’ Top Healthcare Picks: Addex Therapeutics (ADXN), Avidity Biosciences (RNA)
Positive Outlook for Addex Therapeutics: Significant Collaboration Payments and Promising Pipeline Drive Buy Rating
Crude Oil Dips; Addex Therapeutics Shares Spike Higher
Addex stock rallies 45% on Indivior collaboration update